Regen BioPharma Inc. $RGBP is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.
Regen BioPharma is a biotechnology company focused on stem cell and immunotherapies for specialty niche treatments. Currently we are focused on aplastic anemia, gene silencing and small molecule development.”READ MORE”. Complete listing, click December 15, 2015 SOURCE: REGEN BIOPHARMA INC. Regen BioPharma, Inc. Receives FDA Clearance to Initiate Clinical Trial of HemaXellerate.